JCR Pharmaceuticals Co Ltd
TSE:4552
JCR Pharmaceuticals Co Ltd
Common Shares Outstanding
JCR Pharmaceuticals Co Ltd
Common Shares Outstanding Peer Comparison
Competitive Common Shares Outstanding Analysis
Latest Figures & CAGR of Competitors
Company | Common Shares Outstanding | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
J
|
JCR Pharmaceuticals Co Ltd
TSE:4552
|
Common Shares Outstanding
¥124.8m
|
CAGR 3-Years
0%
|
CAGR 5-Years
32%
|
CAGR 10-Years
15%
|
Takeda Pharmaceutical Co Ltd
TSE:4502
|
Common Shares Outstanding
¥1.6B
|
CAGR 3-Years
0%
|
CAGR 5-Years
0%
|
CAGR 10-Years
7%
|
|
Daiichi Sankyo Co Ltd
TSE:4568
|
Common Shares Outstanding
¥1.9B
|
CAGR 3-Years
0%
|
CAGR 5-Years
24%
|
CAGR 10-Years
11%
|
|
Otsuka Holdings Co Ltd
TSE:4578
|
Common Shares Outstanding
¥542.5m
|
CAGR 3-Years
0%
|
CAGR 5-Years
0%
|
CAGR 10-Years
0%
|
|
Chugai Pharmaceutical Co Ltd
TSE:4519
|
Common Shares Outstanding
¥1.6B
|
CAGR 3-Years
0%
|
CAGR 5-Years
0%
|
CAGR 10-Years
12%
|
|
Astellas Pharma Inc
TSE:4503
|
Common Shares Outstanding
¥1.8B
|
CAGR 3-Years
-1%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
-2%
|
See Also
What is JCR Pharmaceuticals Co Ltd's Common Shares Outstanding?
Common Shares Outstanding
124.8m
JPY
Based on the financial report for Mar 31, 2024, JCR Pharmaceuticals Co Ltd's Common Shares Outstanding amounts to 124.8m JPY.
What is JCR Pharmaceuticals Co Ltd's Common Shares Outstanding growth rate?
Common Shares Outstanding CAGR 10Y
15%
Over the last year, the Common Shares Outstanding growth was 0%.